Table 3.
| |||||
---|---|---|---|---|---|
entry | allene | AgOTf:phena,b | d | yield 4 | 5 |
1 | 3a | 1:1.25 | 79% | <4% | |
1:3 | 0% | 81% | |||
Rh2(esp)2 | 35% | 17% | |||
2 | 3b | 1:1.25 | 79% | 13% | |
1:3 | 1% | 76% | |||
3 | 3c | 1:1.25 | 80% | 9% | |
1:3 | 0% | 76% | |||
Rh2(esp)2 | 34% | 34% | |||
4 | 3d | 1:1.25 | 72% | 18% | |
1:3 | 5% | 65% | |||
1:3e | <1% | 71% | |||
5 | 3e | 1:1.25c | 67% | 18% | |
1:3 | 0% | 83% | |||
6 | 3f | 1:1.25 | 87% | 7% | |
1:3 | 0% | 88% | |||
Rh2(esp)2 | 34% | 44% | |||
7 | 3g | 1:1.25 | 70% | 4% | |
1:3 | 0% | 78% | |||
8 | 3h | 1:1.25 | 57% | 12% | |
1:3 | 4% | 74% | |||
1:3e | <1% | 68% | |||
9 | 3i | 1:1.25 | 61% | 0% | |
1:3 | 3% | 74% | |||
1:3e | <1% | 71% | |||
10 | 3j | 1:1.25 | 58% | 0% | |
1:3 | 0% | 36% | |||
1:3e | 2% | 62% |
Aziridination: 20 mol % AgOTf, 25 mol % phen, 2 equiv PhlO, 4 Å MS, CH2Cl2.
C–H insertion: 10 mol % AgOTf, 30 mol % phen, 3.5 equiv PhIO, 4 Å MS, CH2Cl2.
2,2′-bipyridine ligand.
I = insertion. A = aziridination,
10 mol % BHT added